The EMA approves a new formulation of a levodopa-carbidopa combination to treat moderate-to-severe motor fluctuations in patients with Parkinson’s disease.
1don MSN
Dementia-causing substance turns into a therapeutic 'switch' with new Alzheimer's drug strategy
A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new ...
The hereditary disorder Huntington's disease has so far been considered incurable. Its clinical manifestations include ...
New discussion around Parkinson’s treatment is putting dopamine agonists under the spotlight, with clinicians balancing motor ...
Influential economist Alan Greenspan died at 100 from complications of Parkinson's disease. What to know about the diagnosis.
Remepy, a pioneer in Hybrid Drugs™, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into ...
Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...
Chlorpyrifos, a pesticide still legally applied to strawberries, apples, citrus, soybeans, and wheat in most US states, more ...
In a world first Australian researchers will test a one-off therapy that could replace damaged brain cells in people with ...
MONTPELIER, Vt. (AP) — Vermont has become the first U.S. state to ban paraquat, one of the most commonly used herbicides, ...
Researchers say that GLP-1 drugs like Ozempic used to treat type 2 diabetes may impair a person’s sense of taste and smell.
Scientists found a drug that can clear out toxic proteins in the brain, according to a study published in the journal ACS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results